
Myomo (MYO) Stock Forecast & Price Target
Myomo (MYO) Analyst Ratings
Bulls say
Myomo is a wearable medical robotics company that has great potential for growth, due to the recent positive Medicare ruling expanding their market reach. With their MyoPro products and strong commercialization efforts, Myomo estimates a $10 billion addressable market in the U.S. alone, providing a high reward for the risks involved. Additionally, the company has a strong balance sheet and has raised their guidance for future revenue, showing positive growth and potential for the company.
Bears say
Myomo is facing strong headwinds in the market, with only a narrow margin of revenue growth in Q1 2026 and continued losses in EPS. The company also faces significant risks, including balance sheet and liquidity concerns, challenges in gaining regulatory approvals and commercializing products, and intense competition in the industry. Additionally, external factors such as changing market conditions and investor sentiment may impact the company's performance.
This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.
Myomo (MYO) Analyst Forecast & Price Prediction
Start investing in Myomo (MYO)
Order type
Buy in
Order amount
Est. shares
0 shares